Enaltec Labs PVT. Ltd.

Enaltec was established in 2006 with the specific objective to develop and produce niche and technology driven API at competitive prices through its WHO GMP and US FDA approved sites and supply across the world. Enaltec has further strengthen its foothold in generic formulation development through its R&D site Enaltec Pharma Research, having capacity to develop wide range of dosage forms ranging from Solid oral, liquid oral, Derma, Injectable, Potent molecule (Oncology and Hormones), Undertake cGMP analytical method validation and registration ICH stability studies at Enaltec Formulation Labs.
ENALTEC= (API R&D + API Manufacturing) + (Formulation R&D [FFS/Turnkey])

Sub-event: CPhI Worldwide
Zone: API

Contact details

1706, 17th Floor, Kesar Solitaire,
Plot No.5, Sector-19, Sanpada,
400 705
Navi Mumbai